{"version":"1.0","type":"link","title":"Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.","author_name":"Yap TA 외","author_url":"https://prs-insight.online/author/Yap%20TA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167997","thumbnail_width":1200,"thumbnail_height":630}